AVI Global Trust (LSE:AGT) reported a 2.6% fall in net asset value for September, its financial year-end, as an Arnault family offer for Christian Dior provided the standout event of the period.
AVI Global Trust's monthly update, published on 13 October, closed a difficult financial year on a soft note. Net asset value per share fell 2.6% on a sterling total return basis in the month to 30 September, while the MSCI All Country World index gained 0.9% and the same index excluding the US slipped 0.4%.
Over the full 12 months the trust (LSE:AGT) returned 1.7% in NAV terms, compared with 18.3% for the global index and 21.6% for the ex-US measure. The longer-term record is more mixed: the NAV return over 10 years stands at 152.6%, ahead of the 136.8% from the ex-US index but behind the 214.2% from the global benchmark.
About the company
AVI Global Trust is an Investment trust listed in London that invests in a concentrated portfolio of companies around the world. Its manager, Asset Value Investors, looks for businesses whose shares trade at wide discounts to the value of their underlying Assets or operations. These include holding companies, closed-end funds and special situations, and the trust seeks to benefit when those discounts narrow, whether through market recognition, corporate action or Shareholder engagement.
Returns therefore come from two drivers: the performance of the underlying holdings, and the change in the gap between each holding's price and its estimated worth. The approach is patient and company-specific, and it can lead to large positions in a small number of names. D'Ieteren, the largest holding at 6.6% of net assets, shows the scale of single-stock exposure, while Japan and Korea have been meaningful contributors.
Over the latest 12 months the trust returned 1.7% in net asset value terms, well behind the global index, though its 10-year return of 152.6% remains ahead of the ex-US measure. The financial year-end in September closed that period with a 2.6% fall for the month, and the Annual Report and shareholder meeting due in the coming weeks will set out the full year.
Dior delivers an exit
The most notable portfolio development was Christian Dior SE. The Arnault family plans a cash offer at 95% of net asset value for the 2.44% of the company it does not already own, with that value set by reference to the one-month average price of LVMH shares in December 2026 and completion expected in the first quarter of next year.
The manager said Dior's shares rose 16% in a single day on the news and that the discount to underlying value narrowed from 21% to 9%. AVI, which had earlier trimmed about a third of the position at prices of up to €900 a share before adding again over the summer, sold around two-thirds of its holding and retained only a small stake. It put the return on the investment at 51%, equivalent to an annualised 14%.
Bio-Rad Laboratories offered a second positive strand. Established as a new position earlier this year, it has returned about 25% in a few months, according to the manager, who regards the stake in Sartorius, worth about 32% of Bio-Rad, as a central driver of value.
Large positions weighed on the month
The manager called September a relatively lean month for contributors, and the largest holdings accounted for much of the decline. D'Ieteren, the biggest position at 6.6% of net assets, took 63 basis points off returns. Vivendi cost 51 basis points, Chrysalis Investments 41, Samsung C&T 40 and Jardine Matheson 39.
On the positive side, Symphony added 27 basis points, Wacom 26, Rohm 21, Mitsui O.S.K. Lines 20 and Tokyo Gas 13, underlining the continued contribution of the Japanese names in the portfolio.
Looking at the year as a whole, Chrysalis and Vivendi together cost the trust (LSE:AGT) about 781 basis points, by the manager's reckoning, which explains most of the shortfall against global indices. Japan and Korea, by contrast, were solid, with AVI citing returns of about 17% and 44% respectively from those markets.
The manager argued that Vivendi's shares, at a 53% discount to net asset value, do not reflect the fundamentals of Universal Music Group. Chrysalis is described as a multi-year activist campaign in which AVI's funds together form the largest shareholder. For D'Ieteren, the manager pointed to a likely initial public offering of its Belron Subsidiary as a potential catalyst.
How discount-capture investing works
A discount arises when a company is priced below the combined value of the assets or businesses it owns. Holding companies and trusts often sit at such discounts for years, and the opportunity lies in catalysts that close the gap, such as a Takeover offer, a disposal or a change in Capital allocation.
The Christian Dior offer is a clear example, since the discount narrowed sharply once a bid emerged. The flip side is that catalysts can take longer than expected, and positions such as Vivendi and Chrysalis show how a wide discount can persist or widen.
Points to follow after the year-end
The annual report should provide a fuller view of attribution, costs and the trust's own discount to net asset value. Shareholders will also look for commentary on how the proceeds from the Dior sale are redeployed and on progress at Chrysalis, Vivendi and D'Ieteren.
Another point of interest is the discount at which the trust's own shares trade, since the board has tools such as Buybacks to manage it and investors often judge the vehicle partly on that basis. Currency movements, particularly in yen and euro, also affect sterling returns and will feature in the commentary.
Reporting from the manager over the winter will show whether the Dior proceeds are recycled into similar situations, and whether the Japanese holdings continue to offset weakness elsewhere.
Reporting dates ahead
The FTSE 250 trust's annual report is due this month, and the Annual General Meeting is scheduled for 18 December. Those documents should give shareholders a fuller account of a year in which the discount-capture approach produced individual successes, while being outweighed by two large positions that moved against the portfolio.
![ASA International [LSE:ASAI] Jumps Into Focus: What the Small-Cap Microfinance Stock Is Signalling on 11 November](/featured_image/gallery/medium/shutterstock_1305011686_11_11_2026_09_49_57_363836.jpg)
![Barings Emerging EMEA Opportunities [LSE:BEMO] Gains Attention as EMEA Portfolio Mix Shifts: What Investors Watch Next | FTSE SmallCap Small Cap Stock](/featured_image/gallery/medium/shutterstock_2439951387_11_11_2026_09_50_06_944853.jpg)
![Majedie Investments [LSE:MAJE] in Focus Ahead of Its Ex-Dividend Date: What Investors Are Watching | FTSE SmallCap Small Cap Stock](/featured_image/gallery/medium/shutterstock_2738624295_11_11_2026_09_51_19_594128.jpg)
![Mobius Investment Trust [LSE:MMT] Draws Attention as NAV Volatility Puts Emerging Markets Back on the Radar | FTSE SmallCap Small Cap Stock](/featured_image/gallery/medium/shutterstock_593873471_11_11_2026_09_51_24_210190.jpg)
![North Atlantic Smaller Companies [LSE:NAS] in Focus: The Small-Cap Trust Trading at a Deep Discount](/featured_image/gallery/medium/shutterstock_195387089_11_11_2026_09_51_38_467176.jpg)
![Oryx International Growth Fund [LSE:OIG] in Focus as NAV Holds the Key to the Investment Trust Story | FTSE SmallCap Small Cap Stock](/featured_image/gallery/medium/shutterstock_2654943999_11_11_2026_09_51_48_017022.jpg)
Please wait processing your request...